相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Whole Genome-Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non-Small-Cell Lung Cancer
Yuanqing Yan et al.
CANCER RESEARCH (2019)
Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer
Jiejie Qin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Fisher discriminant analysis for classification of autism spectrum disorders based on folate-related metabolism markers
Mingyang Zou et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)
Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2019)
Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma
Jiejie Qin et al.
CANCER SCIENCE (2019)
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial
Sepideh Saadatmand et al.
LANCET ONCOLOGY (2019)
Metabolic Syndrome as a Predictor of Adrenal Functional Status: A Discriminant Multivariate Analysis Versus Logistic Regression Analysis
Charalampos Tsentidis et al.
HORMONE AND METABOLIC RESEARCH (2019)
Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer
Peng Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Protein and glycomic plasma markers for early detection of adenoma and colon cancer
Jung-hyun Rho et al.
GUT (2018)
Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens
James A. Koziol et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
The future of blood-based biomarkers for the early detection of breast cancer
Sau Yeen Loke et al.
EUROPEAN JOURNAL OF CANCER (2018)
Diagnostic Value of the Survivin Autoantibody in Four Types of Malignancies
Yuting Xiu et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2018)
The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells
Junguo Cao et al.
STEM CELLS INTERNATIONAL (2018)
Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer
Shuaibing Wang et al.
ONCOIMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Analysis of blood markers for early breast cancer diagnosis
J. Bayo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer
Ying Liu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
CDK4/6 inhibition triggers anti-tumour immunity
Shom Goel et al.
NATURE (2017)
Diagnostic relevance of a novel multiplex immunoassay panel in breast cancer
Natalie Hermann et al.
TUMOR BIOLOGY (2017)
Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling
S. Goncalves-Ribeiro et al.
ANNALS OF ONCOLOGY (2017)
Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray
Lina Yang et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer
Pei Li et al.
ONCOIMMUNOLOGY (2016)
Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer
Weihong Liu et al.
TUMOR BIOLOGY (2015)
Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
Yi-Wei Xu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma
Liping Dai et al.
CLINICAL IMMUNOLOGY (2014)
Use of Autoantibodies to Detect the Onset of Breast Cancer
Jerome Lacombe et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis
Qing Zhu et al.
AUTOIMMUNITY REVIEWS (2013)
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer
B. Burford et al.
BRITISH JOURNAL OF CANCER (2013)
Autoantibodies against insulin-like growth factor-binding protein-2 as a serological biomarker in the diagnosis of lung cancer
Ying Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer
Hua Ye et al.
ONCOLOGY LETTERS (2013)
Evaluation of Known Oncoantibodies, HER2, p53, and Cyclin B1, in Prediagnostic Breast Cancer Sera
Hailing Lu et al.
CANCER PREVENTION RESEARCH (2012)
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Archie Bleyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis
Weihong Liu et al.
AUTOIMMUNITY REVIEWS (2011)
Serum autoantibodies as biomarkers for early cancer detection
Hwee Tong Tan et al.
FEBS JOURNAL (2009)
Autoantibodies to tumor-associated antigens: reporters from the immune system
Eng M. Tan et al.
IMMUNOLOGICAL REVIEWS (2008)
Autoantibodies in breast cancer: their use as an aid to early diagnosis
C. Chapman et al.
ANNALS OF ONCOLOGY (2007)
T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease
H Suzuki et al.
CLINICAL CANCER RESEARCH (2005)